Executives from leading pharmaceutical and technology and automation companies size up the pharmacy space as we move into the second year of the pandemic and pharmacies continue to play a crucial role in COVID-19 vaccinations.
Advair Diskus has a market value of approximately $3 billion for the 12 months ended February 2021, although actual generic market values are expected to be lower.
The tentative approval applies to the chronic lymphocytic leukemia/small lymphocytic lymphoma treatment in strengths of 560 mg, 420 mg, 280 mg, and 140 mg.